About Oculogenex
Oculogenex is a company based in La Habra (United States) founded in 2020 by Ram Ramkumar.. Oculogenex offers products and services including Gene Therapy for Macular Degeneration. Oculogenex operates in a competitive market with competitors including EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others.
- Headquarter La Habra, United States
- Founders Ram Ramkumar
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$256 K (USD), Grant
May 01, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oculogenex
Oculogenex offers a comprehensive portfolio of products and services, including Gene Therapy for Macular Degeneration. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational therapy to stop vision degeneration in retinal diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Oculogenex
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $256,000
-
First Round
First Round
(01 May 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Grant - Oculogenex | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oculogenex
Oculogenex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oculogenex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oculogenex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oculogenex Comparisons
Competitors of Oculogenex
Oculogenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyePoint Pharmaceuticals, Rezolute, Molecular Partners, Aviceda Therapeutics and IVERIC bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Gene therapy solutions for retinal diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for ophthalmological diseases are developed to restore vision.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oculogenex
Frequently Asked Questions about Oculogenex
When was Oculogenex founded?
Oculogenex was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Oculogenex located?
Oculogenex is headquartered in La Habra, United States. It is registered at La Habra, California, United States.
What does Oculogenex do?
Oculogenex was founded in 2020 and is based in La Habra, United States. Operations focus on the biotechnology sector, where gene therapies for eye disorders are developed. An ocular regenerative product is delivered via intravitreal injection to address central vision degeneration in macular degeneration patients. Development targets ophthalmological conditions through targeted genetic interventions.
Who are the top competitors of Oculogenex?
Oculogenex's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.
What products or services does Oculogenex offer?
Oculogenex offers Gene Therapy for Macular Degeneration.
Who are Oculogenex's investors?
Oculogenex has 1 investor. Key investors include National Science Foundation.